Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia
Neuropsychopharmacology · 2024
DOI: 10.1038/s41386-024-01975-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology, 2024. Verfasst von Mark Slifstein und 10 weiteren Autor:innen. Beteiligte Einrichtung: Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA. mark.slifstein@stonybrookmedicine.edu. Hauptthemen laut MEDLINE: Receptors, Opioid, kappa, Anhedonia, Positron-Emission Tomography, Schizophrenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH), NIMH NIH HHS.
Abstract (Originalsprache)
The kappa opioid receptor (KOR) and its endogenous agonist dynorphin have been implicated in multiple psychiatric conditions including psychotic disorders. We tested the hypotheses that kappa expression is elevated and associated with psychotic symptoms in schizophrenia. We measured kappa expression in unmedicated patients with schizophrenia (7 female, 6 male) and matched controls (7 female, 6 male) with positron emission tomography (PET). We also acquired a measurement of cumulative dopamine activity over the life span in the same subjects using neuromelanin sensitive MRI. We hypothesized that neuromelanin accumulation would be higher in patients than controls and that in patients there would be a positive association between KOR availability and neuromelanin accumulation. Fourteen patients and thirteen controls were enrolled. Whole brain dynamic PET imaging data using the KOR selective tracer [18F]LY245998 were acquired. Distribution volume (VT) was measured with region of interest analysis in 14 brain regions. Neuromelanin accumulation in midbrain dopaminergic nuclei was assessed in the same subjects. Positive and negative symptoms were measured by a clinical psychologist. We did not observe group level differences in KOR expression, neuromelanin accumulation or relationships of these to positive symptoms. Unexpectedly, we did observe strong positive associations between KOR expression and symptoms of anhedonia in the patients (Pearson r > 0.7, uncorrected p < 0.01 in 8 cortical brain regions). We also observed moderate associations between KOR expression and neuromelanin levels in patients. In conclusion, we did not observe a relationship between kappa and symptoms of psychosis but the observed relationship to the negative symptom of anhedonia is in line with recent work testing kappa antagonism as a therapy for anhedonia in depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA. mark.slifstein@stonybrookmedicine.edu.
- Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Vagelos College of Physicians and Surgeons, Columbia University, Stony Brook, New York, USA.
- New York State Psychiatric Institute, Stony Brook, New York, USA.
ORCID-Profile: Jodi J Weinstein, Greg Perlman, Scott J Moeller
Förderung
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- NIMH NIH HHS
Zitieren
APA
Slifstein, M., Qu, W., Gil, R., Weinstein, J. J., Perlman, G., Jaworski-Calara, T., Meng, J., Hu, B., Moeller, S. J., Horga, G., & Abi-Dargham, A. (2024). Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01975-3
Vancouver
Slifstein M, Qu W, Gil R, Weinstein JJ, Perlman G, Jaworski-Calara T, et al. Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia. Neuropsychopharmacology. 2024. doi:10.1038/s41386-024-01975-3
BibTeX
@article{Slifstein2024,
author = {Slifstein, Mark and Qu, Wenchao and Gil, Roberto and Weinstein, Jodi J and Perlman, Greg and Jaworski-Calara, Thomas and Meng, Jiayan and Hu, Bao and Moeller, Scott J and Horga, Guillermo and Abi-Dargham, Anissa},
title = {Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia},
journal = {Neuropsychopharmacology},
year = {2024},
doi = {10.1038/s41386-024-01975-3}
}
EUVIMED